ERBB2 and neoplasm: The results documented that MDA-7/IL-24 expression could delay tumor onset in MMTV-MDA-7/MMTV-Erbb2 compound transgenic mice, and could also suppress tumor growth and exhibit “bystander” antitumor effects in MMTV-PyMT mice.